NDC 43742-0170

Oratox

Fucus Vesiculosus, Lymph Node, Medulla Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum,

Oratox is a Oral Liquid in the Human Prescription Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Fucus Vesiculosus; Sus Scrofa Lymph; Sus Scrofa Bone Marrow; Sus Scrofa Thymus; Sus Scrofa Thyroid; Calcium Chloride; Iodine; Sodium Fluoride; Sodium Chloride; Selenium; Vanadium; Silver; Gold; Copper; Eugenol; Formaldehyde; Lidocaine; Mercurius Solubilis; Molybdenum; Nickel; Palladium; Tin; Titanium; Zinc.

• Product ID: 43742-0170_e663e2c9-af1c-44e5-a472-ca5fb62ab93d
• NDC: 43742-0170
• Product Type: Human Prescription Drug
• Proprietary Name: Oratox
• Generic Name: Fucus Vesiculosus, Lymph Node, Medulla Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum,
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2012-10-31
• Marketing End Date: 2020-12-02
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Deseret Biologicals, Inc.
• Substance Name: FUCUS VESICULOSUS; SUS SCROFA LYMPH; SUS SCROFA BONE MARROW; SUS SCROFA THYMUS; SUS SCROFA THYROID; CALCIUM CHLORIDE; IODINE; SODIUM FLUORIDE; SODIUM CHLORIDE; SELENIUM; VANADIUM; SILVER; GOLD; COPPER; EUGENOL; FORMALDEHYDE; LIDOCAINE; MERCURIUS SOLUBILIS; MOLYBDENUM; NICKEL; PALLADIUM; TIN; TITANIUM; ZINC
• Active Ingredient Strength: 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
• Pharm Classes: Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Allergens [CS],Cell-mediated Immunity [PE],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS]
• NDC Exclude Flag: N

Packaging

NDC 43742-0170-1

30 mL in 1 BOTTLE, DROPPER (43742-0170-1)

• Marketing Start Date: 2012-10-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 43742-0170-1 [43742017001]

Oratox LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-10-31
• Marketing End Date: 2020-12-02

Drug Details

Active Ingredients

Ingredient	Strength
FUCUS VESICULOSUS	3 [hp_X]/mL

OpenFDA Data

• SPL SET ID: fd3b2868-746d-48a2-acaa-17b926bc7c6e
• Manufacturer:
  • Deseret Biologicals, Inc.
• UNII:
  • M4I0D6VV5M
  • 3M4G523W1G
  • 387GMG9FH5
  • 8ZYQ1474W7
  • 451W47IQ8X
  • 535G2ABX9M
  • 1HG84L3525
  • 3T8H1794QW
  • VP2CN2G7Y8
  • 7OV03QG267
  • J41CSQ7QDS
  • H6241UJ22B
  • 33A7VYU29L
  • 81AH48963U
  • D1JT611TNE
  • 7B69B0BD62
  • 00J9J9XKDE
  • 6RV024OAUQ
  • 79Y1949PYO
  • 5TWQ1V240M
  • 324Y4038G2
  • 98PI200987
  • 789U1901C5
  • 9679TC07X4

Pharmacological Class

• Blood Coagulation Factor [EPC]
• Increased Coagulation Factor Activity [PE]
• Calcium [CS]
• Cations
• Divalent [CS]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Allergens [CS]
• Cell-mediated Immunity [PE]
• Copper [CS]
• Copper-containing Intrauterine Device [EPC]
• Decreased Embryonic Implantation [PE]
• Decreased Sperm Motility [PE]
• Inhibit Ovum Fertilization [PE]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Blood Coagulation Factor [EPC]
• Increased Coagulation Factor Activity [PE]
• Calcium [CS]
• Cations
• Divalent [CS]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Allergens [CS]
• Cell-mediated Immunity [PE]
• Copper [CS]
• Copper-containing Intrauterine Device [EPC]
• Decreased Embryonic Implantation [PE]
• Decreased Sperm Motility [PE]
• Inhibit Ovum Fertilization [PE]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Amide Local Anesthetic [EPC]
• Amides [CS]
• Antiarrhythmic [EPC]
• Local Anesthesia [PE]
• Standardized Chemical Allergen [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]

NDC Crossover Matching brand name "Oratox" or generic name "Fucus Vesiculosus, Lymph Node, Medulla Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum,"

NDC	Brand Name	Generic Name
43742-0170	Oratox	Fucus Vesiculosus, Lymph Node, Medulla Ossis Suis, Thymus, Thyroidinum, Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum,
43742-0775	Oratox	Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenia Caryophyllata, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum
43742-0944	Oratox	Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum